Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, December 18, 2014
Technology Networks
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
Anti-Diabetic Drug Springs New Hope for Tuberculosis Patients
Drug for treating diabetes can double up as adjunct treatment for tuberculosis.
A Poisonous Cure
Toxic fungi may hold the secrets to tackling deadly diseases.
Antibiotic Resistance Threatens Future of Modern Medicine
Overuse and misuse of antibiotics, one of the key contributors to antimicrobial resistance (AMR).
Bacterial Toxin Targets Discovered
Understanding how bacterial toxins target human cells is set to have major implications for the development of novel drugs.
Proteomics for Systems Toxicology
MS-based proteomics is maturing into a robust technology for the measurement of proteome-wide exposure effects.
Molecular Event Mapping Opens Door to more in silico Tests
It is hoped that this new approach to mapping and predicting the impact of chemical compounds in the body could reduce the need for toxicity tests in animals.
Protein-engineered Cages Aid Studies of Cell Functions
The Cages, from researchers at Tokyo Institute of Technology, to deliver an important signalling molecule, carbon monoxide, into cells.
Wallet-Sized Labs The Next Big Thing
RMIT researchers are developing inexpensive, portable toxicology laboratories so small you could fit them in your wallet.
Altered Milk Protein Can Deliver AIDS Drug to Infants
Binding with an antiretroviral drug promises to greatly improve treatment for infants and young children suffering from HIV/AIDS.
New Drug for Common Liver Disease Improves Liver Health
An experimental drug aimed at treating a common liver disease showed promising results and potential problems in a multicenter clinical trial funded by the NIH.
Scroll Up
Scroll Down
Return
Metabolomics as a Tool for Biomarker Discovery
Dr. Chris Beecher, Vice President of Biochemistry and Technology, Metabolon, Inc., speaking at Advances in Metabolic Profiling 2005
Date Posted: Friday, May 12, 2006
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



Metabolomics Technology Applied to Non-Invasive Nash Biomarkers Research
Metabolon studied plasma profiles from subjects with nonalcoholic fatty liver disease.
Monday, May 17, 2010
Patents Awarded to Metabolon for Metabolomics Methods
The USPTO patents cover uses of metabolomics to identify diagnostic biomarkers for depression and schizophrenia.
Thursday, April 01, 2010
Metabolomics Aids in Understanding Mechanisms of Commonly Used Drugs
Metabolon announces publication of a new study which seeks to understand toxicological effects of Fenofibrate.
Thursday, August 13, 2009
Metabolon Announces First in a Series of new Research Tools
Metabolon releases mFocus TST™, a research use only assay for prostate cancer progression.
Wednesday, February 25, 2009
Metabolon Acquires Intellectual Property from Cogenics Icoria
Metabolon acquires the property portfolio including patents related to metabolomics methods and data analysis, carcinogenicity and toxicity biomarkers.
Wednesday, November 07, 2007
 
SELECTBIO
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn